Tuberous Sclerosis Complex as Disease Model for Investigating mTOR-Related Gliopathy During Epileptogenesis

Cites (263)

Items 201–263 of 263

1. Blood–brain barrier leakage after status epilepticus in rapamycin‐treated rats I: Magnetic resonance imaging
   Erwin Alexander van Vliet, Willem M. Otte, Wytse Jan Wadman, Eleonora Aronica, Gijs Kooij, Helga E. de Vries, Rick M. Dijkhuizen, Jan A. Gorter · 2015 · Epilepsia
2. Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study
   Gupta, Ajay, de Bruyn, Gwendolyn, Tousseyn, Simon, Krishnan, Balu, Lagae, Lieven, Agarwal, Nitin, Minnesota Epilepsy Group, Frost, Michael, Sparagana, Steven, LaJoie, Josiane et al. · 2020 · Pediatric Neurology
3. The Natural History and Treatment of Epilepsy in a Murine Model of Tuberous Sclerosis
   Ebru Erbayat Altay, Linghui Zeng, Lin Xu, David H. Gutmann, Michael L. Wong · 2007 · Epilepsia
4. Epileptogenicity in tuberous sclerosis complex: A stereoelectroencephalographic study
   Andrew J. Neal, Karine Ostrowsky‐Coste, Julien Jung, Stanislas Lagarde, Louis Georges Maillard, Philippe Kahane, Renaud L. Touraine, Hélène Catenoix, Alexandra Montavont, Jean Isnard et al. · 2019 · Epilepsia
5. Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex
   Emma A. van der Poest Clement, Floor E. Jansen, Kees P. J. Braun, Jurriaan M. Peters · 2020 · Pediatric Drugs
6. Diffusion Features of White Matter in Tuberous Sclerosis With Tractography
   Michelle L. Krishnan, Olivier Commowick, Shafali Jeste, Neil Weisenfeld, Arne Hans, Matthew C. Gregas, Mustafa Şahin, Simon Keith Warfield · 2010 · Pediatric Neurology
7. Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment
   James Dominic Mills, Anand M. Iyer, Jackelien van Scheppingen, Anika Bongaarts, Jasper J. Anink, Bart J. Janssen, Till S. Zimmer, Wim G.M. Spliet, Peter C. van Rijen, Floor E. Jansen et al. · 2017 · Scientific Reports
8. Oligodendrocyte Gap Junction Loss and Disconnection From Reactive Astrocytes in Multiple Sclerosis Gray Matter
   Kyriaki Markoullis, Irene Sargiannidou, Natasa Schiza, Federico Roncaroli, Richard Reynolds, Kleopas A. Kleopa · 2014 · Journal of Neuropathology & Experimental Neurology
9. Balloon cells in human cortical dysplasia and tuberous sclerosis: isolation of a pathological progenitor-like cell
   Shireena A. Yasin, K Latak, Francesca Becherini, Anita Ganapathi, Khadijah Miller, Oliver Campos, Simon R. Picker, Nelly Bier, Martin Smith, Maria Thom et al. · 2010 · Acta Neuropathologica
10. Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA‐derived cell cultures
    van Scheppingen, J., Iyer, A. M., Prabowo, A. S., Mühlebner, A., Anink, J. J., Scholl, T., Feucht, M., Jansen, F. E., Spliet, W. G., Krsek, P. et al. · 2016 · Glia
11. Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex
    Karin Boer, Dirk Troost, Wendy Timmermans, Jan A. Gorter, Wim G.M. Spliet, Mark D. Nellist, Floor E. Jansen, Eleonora Aronica · 2008 · Neuroscience
12. Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions
    Avanita S. Prabowo, Anand M. Iyer, Jasper J. Anink, Wim G.M. Spliet, Peter C. van Rijen, Eleonora Aronica · 2013 · Journal of Neuroinflammation
13. The role of glia in epilepsy, intellectual disability, and other neurodevelopmental disorders in tuberous sclerosis complex
    Michael Wong · 2019 · Journal of Neurodevelopmental Disorders
14. Everolimus dosing recommendations for tuberous sclerosis complex– associated refractory seizures
    David Neal Franz, John A. Lawson, Zühal Yapıcı, Christian Brandt, Michael H. Kohrman, Michael Wong, Mathieu Milh, Adelheid Wiemer‐Kruel, Maurizio Voi, Neva Coello et al. · 2018 · Epilepsia
15. An update on the central nervous system manifestations of tuberous sclerosis complex
    Jennifer A. Cotter · 2019 · Acta Neuropathologica
16. Astrocytes and Epilepsy
    Devin K Binder, Christian Steinhäuser · 2016 · Elsevier eBooks
17. Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models
    Laura Magri, Manuela Cominelli, Marco Cambiaghi, Marco Cursi, Letizia Leocani, Fabio Minicucci, Pietro Luigi Poliani, Rossella Galli · 2013 · Disease Models & Mechanisms
18. Genomic analysis of the molecular neuropathology of tuberous sclerosis using a human stem cell model
    Nils Grabole, Jitao David Zhang, Stefan Aigner, Nadine Ruderisch, Veronica Costa, Felix C. Weber, Michel Theron, Nikolaos Berntenis, Olivia Spleiss, Martin Ebeling et al. · 2016 · Genome Medicine
19. Early white matter development is abnormal in tuberous sclerosis complex patients who develop autism spectrum disorder
    on behalf of the TACERN Study Group, Anna K. Prohl, Benoît Scherrer, Xavier Tomas-Fernandez, Peter E. Davis, Rajna Filip‐Dhima, Sanjay P. Prabhu, Jurriaan M. Peters, Elizabeth Martina Bebin, Darcy A. Krueger et al. · 2019 · Journal of Neurodevelopmental Disorders
20. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex
    Zhang, Bo, Zou, Jia, Han, Lirong, Beeler, Brennan, Friedman, Joseph L., Griffin, Elizabeth, Piao, Yue‐Shan, Rensing, Nicholas R., Wong, Michael · 2018 · Epilepsia
21. Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex
    Nicholas R. Rensing, Lirong Han, Michael L. Wong · 2015 · Epilepsia
22. Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures
    Ming-Tao Yang, Yi-Chin Lin, W. Ho, Chao-Lin Liu, Wang-Tso Lee · 2017 · Journal of Neuroinflammation
23. Mechanistic Target of Rapamycin Regulates the Oligodendrocyte Cytoskeleton during Myelination
    Aminat S. Musah, Tanya L. Brown, Marisa A. Jeffries, Quan Shang, H Hashimoto, Angelina V. Evangelou, Alison Kowalski, Mona Batish, Wendy B. Macklin, Teresa L. Wood · 2020 · Journal of Neuroscience
24. Blood–brain barrier leakage after status epilepticus in rapamycin‐treated rats II : Potential mechanisms
    Erwin Alexander van Vliet, Willem M. Otte, Wytse Jan Wadman, Eleonora Aronica, Gijs Kooij, Helga E. de Vries, Rick M. Dijkhuizen, Jan A. Gorter · 2015 · Epilepsia
25. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex
    Fei‐Ji Sun, Chunqing Zhang, Xin Chen, Yujia Wei, Song Li, Shiyong Liu, Zhenle Zang, Jiaojiang He, Wei Guo, Hui Yang · 2016 · Journal of Neuroinflammation
26. Microglial activation during epileptogenesis in a mouse model of tuberous sclerosis complex
    Bo Zhang, Jia Zou, Lirong Han, Nicholas R. Rensing, Michael L. Wong · 2016 · Epilepsia
27. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex
    Song Li, Sixun Yu, Chunqing Zhang, Haifeng Shu, Shiyong Liu, Ning An, Meihua Yang, Qing Yin, Hui Yang · 2012 · Brain Research
28. Diffusion Tensor Imaging of Commissural and Projection White Matter in Tuberous Sclerosis Complex and Correlation with Tuber Load
    Gustavo Novelino Simão, Charles Raybaud, Sylvester H. Chuang, Cristina Go, O. Carter Snead, Elysa Widjaja · 2010 · American Journal of Neuroradiology
29. Human fetal radial glia cells generate oligodendrocytes in vitro
    Zhicheng Mo, Nada Zečević · 2008 · Glia
30. Epilepsy surgery in tuberous sclerosis: The Dutch experience
    Floor E. Jansen, Alexander C. van Huffelen, Peter C. van Rijen, Frans S. S. Leijten, A. Jennekens-Schinkel, Peter H. Gosselaar, Onno van Nieuwenhuizen · 2007 · Seizure
31. Local epileptogenic networks in tuberous sclerosis complex: A case review
    Deepak Madhavan, Howard L. Weiner, Chad Carlson, Orrin Devinsky, Ruben Kuzniecky · 2007 · Epilepsy & Behavior
32. In situ Vaccination Combined with Androgen Ablation and Regulatory T-Cell Depletion Reduces Castration-Resistant Tumor Burden in Prostate-Specific Pten Knockout Mice
    Elizabeth J. Akins, Miranda L. Moore, Shuai Tang, Mark C. Willingham, Janet Austin Tooze, Purnima Dubey · 2010 · Cancer Research
33. The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas
    Anika Bongaarts, Jackelien van Scheppingen, Anatoly Korotkov, Caroline Mijnsbergen, Jasper J. Anink, Floor E. Jansen, Wim G.M. Spliet, Wilfred F.A. den Dunnen, Victoria‐Elisabeth Gruber, Theresa O. Scholl et al. · 2019 · Brain
34. Expression of Astrocyte-Related Receptors in Cortical Dysplasia With Intractable Epilepsy
    Sayuri Sukigara, Hongmei Dai, Shin Nabatame, Taisuke Otsuki, Sae Hanai, Ryoko Honda, Takashi Kei SAITO, Eiji Nakagawa, Takanobu Kaido, Noriko Sato et al. · 2014 · Journal of Neuropathology & Experimental Neurology
35. Platelet regulates neuroinflammation and restores blood–brain barrier integrity in a mouse model of traumatic brain injury
    Cheng Gao, Haochen Wang, Tao Wang, Chengliang Luo, Zufeng Wang, Mingyang Zhang, Xiping Chen, Luyang Tao · 2020 · Journal of Neurochemistry
36. Chronic activation of anti‐oxidant pathways and iron accumulation in epileptogenic malformations
    Till S. Zimmer, Giulia Ciriminna, Andrea Arena, Jasper J. Anink, A. Korotkov, Floor E. Jansen, Wim Van Hecke, Wim G.M. Spliet, Peter C. van Rijen, Johannes C. Baayen et al. · 2019 · Neuropathology and Applied Neurobiology
37. Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age‐dependent manner
    Jia Zou, Bo Zhang, David H. Gutmann, Michael L. Wong · 2017 · Epilepsia
38. Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex
    Wardiya Afshar Saber, Mustafa Şahin · 2020 · Molecular Autism
39. Dual reporter approaches for identification of Cre efficacy and astrocyte heterogeneity
    Joachim Degen, Pavel Dublin, Jiong Zhang, Radek Dobrowolski, Melanie Jokwitz, Khalad Karram, Jacqueline Trotter, Ronald Jabs, Klaus Willecke, Christian Steinhäuser et al. · 2012 · The FASEB Journal
40. Loss of mTORC2 signaling in oligodendrocyte precursor cells delays myelination
    Mark D. Grier, Kathryn L. West, Nathaniel D. Kelm, Cary Fu, Mark D. Does, Brittany Parker, Eleanor McBrier, Andre Hollis Lagrange, Kevin C. Ess, Robert P. Carson · 2017 · PLoS ONE
41. Mechanistic target of rapamycin (mTOR) signaling in status epilepticus
    Peter B. Crino · 2019 · Epilepsy & Behavior
42. Comparative analysis ofTsc1andTsc2single and double radial glial cell mutants
    Ulrike Mietzsch, James Timothy McKenna, R. Michelle Reith, Sharon W. Way, Michael J. Gambello · 2013 · The Journal of Comparative Neurology
43. Everolimus (RAD001) ameliorates vascular cognitive impairment by regulating microglial function via the mTORC1 signaling pathway
    Li Chen, Yanjun Zhang, Daojing Li, Nong Zhang, Ruiqiong Liu, Bin Han, Changjuan Wei, Haijie Liu, Xiaolin Xu, Junwei Hao · 2016 · Journal of Neuroimmunology
44. Neuronal mTORC1 Is Required for Maintaining the Nonreactive State of Astrocytes
    Yue Zhang, Song Xu, Kangyan Liang, Kai Li, Zhipeng Zou, Cuilan Yang, Kang Tan, Xiong Cao, Yu Jiang, Tianming Gao et al. · 2016 · Journal of Biological Chemistry
45. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development
    Jackelien van Scheppingen, Diede W. M. Broekaart, Theresa O. Scholl, Mark R. J. Zuidberg, Jasper J. Anink, Wim G.M. Spliet, Peter C. van Rijen, Thomas Czech, Johannes Andreas Hainfellner, Martha Feucht et al. · 2016 · Journal of Neuroinflammation
46. Longitudinal Effects of Everolimus on White Matter Diffusion in Tuberous Sclerosis Complex
    Jurriaan M. Peters, Anna K. Prohl, Kush Kapur, Audrey R. Nath, Benoît Scherrer, Sean Clancy, Sanjay P. Prabhu, Mustafa Şahin, David Neal Franz, Simon Keith Warfield et al. · 2018 · Pediatric Neurology
47. Rapamycin for Treatment of Epilepsy: Antiseizure, Antiepileptogenic, Both, or Neither?
    Michael Wong · 2011 · Epiliepsy currents/Epilepsy currents
48. Changes in the proliferative capacity of NG2 cell subpopulations during postnatal development of the mouse hippocampus
    Behrouz Moshrefi-Ravasdjani, Pavel Dublin, Gerald Seifert, Katja Jennissen, Christian Steinhäuser, Karl W. Kafitz, Christine R. Rose · 2016 · Brain Structure and Function
49. Increased matrix metalloproteinases expression in tuberous sclerosis complex: modulation by microRNA 146a and 147bin vitro
    Diede W. M. Broekaart, Jackelien van Scheppingen, Jasper J. Anink, Laura Wierts, Bert van het Hof, Floor E. Jansen, Wim G.M. Spliet, Peter C. van Rijen, Wouter W. Kamphuis, Helga E. de Vries et al. · 2019 · Neuropathology and Applied Neurobiology
50. Doublecortin‐like (DCL) expression in focal cortical dysplasia and cortical tubers
    Karin Boer, Paul John Lucassen, Wim G.M. Spliet, Erno Vreugdenhil, Peter C. van Rijen, Dirk Troost, Floor E. Jansen, Eleonora Aronica · 2009 · Epilepsia
51. Astrocytes: Stars of the Sacred Disease
    Devin K. Binder · 2018 · Epiliepsy currents/Epilepsy currents
52. PTEN negatively regulates the cell lineage progression from NG2+ glial progenitor to oligodendrocyte via mTOR-independent signaling
    Estíbaliz González‐Fernández, Hey‐Kyeong Jeong, Masahiro Fukaya, Hyukmin Kim, Rabia R. Khawaja, Isha N. Srivastava, Ari Waisman, Young‐Jin Son, Shin Hyeok Kang · 2018 · eLife
53. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination
    Lauren E. McLane, Jennifer N. Bourne, Angelina V. Evangelou, Luipa Khandker, Wendy B. Macklin, Teresa L. Wood · 2017 · Journal of Neuroscience
54. Dysregulation of the MMP/TIMP Proteolytic System in Subependymal Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex: Modulation of MMP by MicroRNA-320d In Vitro
    Anika Bongaarts, Jody M. de Jong, Diede W. M. Broekaart, Jackelien van Scheppingen, Jasper J. Anink, Caroline Mijnsbergen, Floor E. Jansen, Wim G.M. Spliet, Wilfred F.A. den Dunnen, Victoria‐Elisabeth Gruber et al. · 2020 · Journal of Neuropathology & Experimental Neurology
55. Longitudinal Changes in Diffusion Properties in White Matter Pathways of Children With Tuberous Sclerosis Complex
    Fiona Mitchell Baumer, Jae W. Song, Paul D. Mitchell, Rudolph Pienaar, Mustafa Şahin, Patricia Ellen Grant, Emi Takahashi · 2015 · Pediatric Neurology
56. The Intracellular Cleavage Product of the NG2 Proteoglycan Modulates Translation and Cell-Cycle Kinetics via Effects on mTORC1/FMRP Signaling
    Tanmoyita Nayak, Jacqueline Trotter, Dominik Sakry · 2018 · Frontiers in Cellular Neuroscience
57. Expression of the interleukin 17 in cortical tubers of the tuberous sclerosis complex
    Jiaojiang He, Ke‐Fu Wu, Song Li, Haifeng Shu, Chunqing Zhang, Shiyong Liu, Meihua Yang, Qing Yin, Hui Yang · 2013 · Journal of Neuroimmunology
58. Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase
    Anna R. Malik, Ewa Liszewska, Agnieszka Skalecka, Małgorzata Urbańska, Anand M. Iyer, Lukasz J. Swiech, Małgorzata Perycz, Kamil Parobczak, Patrycja Pietruszka, Malgorzata M. Zarebska et al. · 2015 · Acta Neuropathologica Communications
59. Cerebral aquaporin-4 expression is independent of seizures in tuberous sclerosis complex
    Brittany Short, Lindsay K. Klofas, Hannah J. Harmsen, Bo Zhang, Michael L. Wong, Kevin C. Ess, Cary Fu, Robert Partlow Naftel, Matthew M. Pearson, Robert P. Carson · 2019 · Neurobiology of Disease
60. Childhood white matter disorders: much more than just diseases of myelin
    Marianna Bugiani, Marjo S. van der Knaap · 2017 · Acta Neuropathologica
61. Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
    2000 · Pure Amsterdam UMC
62. Long-term use of mTORC1 inhibitors in tuberous sclerosis complex associated neurological aspects
    Romina Moavero, Paolo Curatolo · 2020 · Expert Opinion on Orphan Drugs
63. Untitled work
    Yamauchi · 2000 · 10.1002/1097-4547(20001115)62:4